Evidence map›Paper›PMID 33475823›Full record

Observational studyJournal of neurology2021

Adjunctive steroids in adults with encephalitis: a propensity score analysis.

Ambreen Allana, Mohammed Samannodi, Michael A Hansen, Stacia DeSantis, Lauren T Ho, Rodrigo Hasbun

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Journal of neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 2 countries.

Ambreen AllanaDivision of Infectious Diseases, UT Health Science Center At Houston, McGovern Medical School, 6431 Fannin St. MSB 2.112, Houston, TX, 77030, USA.
Mohammed SamannodiDivision of Infectious Diseases, UT Health Science Center At Houston, McGovern Medical School, 6431 Fannin St. MSB 2.112, Houston, TX, 77030, USA.
Michael A HansenDepartment of Family and Community Medicine, Baylor College of Medicine, Houston, TX, 77030, USA.
Stacia DeSantisDepartment of Biostatistics, UT School of Public Health, Dallas, TX, 75235, USA.
Lauren T HoEmory University, Atlanta, GA, 30322, USA.
Rodrigo HasbunDivision of Infectious Diseases, UT Health Science Center At Houston, McGovern Medical School, 6431 Fannin St. MSB 2.112, Houston, TX, 77030, USA. Rodrigo.Hasbun@uth.tmc.edu.ORCID http://orcid.org/0000-0002-4155-7089
Baylor College of Medicine · USEmory University · USThe University of Texas Health Science Center · USThe University of Texas Health Science Center at Houston · USUmm al-Qura University · SAUniversity of Texas Health Science Center at Dallas · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAdjuvant steroids have been used for the treatment of encephalitis, although there is limited data regarding its benefit. We described the use and impact of adjunctive steroids on adverse clinical outcomes (ACO) in adults with encephalitis.

methodsRetrospective observational study of 230 adults with encephalitis at two tertiary care hospital systems in Houston, Texas, between August 2008 and September 2017. An ACO was assessed at the time of death or discharge and defined as a Glasgow Outcome Scale 1-4. A propensity score analysis was performed.

resultsOut of 230 adult encephalitis patients enrolled, 121 (52.6%) received steroids. Adjunctive steroids were given more frequently to those who had focal neurological deficits (P = 0.01), required mechanical ventilation (MV) (P = 0.01), had intensive care unit admission (P < 0.001), had white matter abnormalities (P = 0.01) or cerebral edema on magnetic resonance imaging of the brain (P = 0.003). An ACO was seen in 135 (58.7%) of patients. The use of adjunctive steroids did not impact ACOs (P = 0.52) on univariate analyses or after propensity score matching. Predictors for an ACO in logistic regression analyses included a Glasgow Coma Score (GCS) < 8, fever, MV, and cerebral edema.

interpretationAdjunctive steroids are used more frequently in sicker patients and are not associated with improved clinical outcomes.

Indexed as

EncephalitisAdultGlasgow Coma ScaleHumansPropensity ScoreRetrospective StudiesSteroidsSteroidsAdjunctive steroidsAdultsEncephalitisOutcomes

Identifiers

PMID33475823
OpenAlexW3125828097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.